Peter R. Kelso

Peter Kelso is a Principal in the ECA practice and leads Roux’s Environmental, Social, Governance (ESG) practice. Mr. Kelso provides strategic advisory and expert witness services to corporate and insurance clients throughout the United States on product and environmental litigation matters. Mr. Kelso’s expertise in ESG-related regulatory, investment, and environmental matters is valued by clients seeking to plan, manage, and develop solutions to mitigate environmental risk.

Mr. Kelso has been at the forefront of identifying emerging litigation trends for over 20 years. He is an expert on mass tort and product liability litigation and advises clients on identifying and finding solutions for risks associated with legacy liabilities and emerging litigation. Mr. Kelso advises clients on litigation risk, providing them with expertise in product liability litigation, insurance coverage negotiations, due diligence for mergers and acquisitions, liability ring fencing activities, and bankruptcy reorganizations. He has led and supported numerous public policy initiatives to effectuate judicial and legislative reform at the state and federal levels.

Mr. Kelso has advised Fortune 100 companies, international insurers and reinsurers, and many of the top investment firms on Wall Street on quantifying current and future potential costs associated with litigation outcomes. He has given numerous speeches for the financial and legal communities at conferences hosted by Goldman Sachs, Citigroup, Bank of America Securities, American Bar Association, Brookings Institute, RAND, LexisNexis, and Perrin Conferences. Mr. Kelso currently leads a working group of top international corporations and insurers on examining the risks associated with asbestos and other toxic tort litigation. Mr. Kelso was elected to the 2021 board of the National Forum for Environmental Toxic Tort Issues (FETTI).

• Consulting lead to develop incidence and dose-response model for talc and asbestos-related exposures.
• Strategic consultant in national opioid litigation to create liability and allocation model from publicly available data.
• Consulting lead to assess alternative exposures associated with bankrupt products on a portfolio of asbestos personal injury cases.
• Strategic consultant to assess the potential risk associated with alleged ethylene oxide exposures.
• Strategic consultant on behalf of an insurer to estimate potential economic damages in a public water contamination case.
• Strategic consultant on public policy issues related to efforts to enact state and federal asbestos trust transparency legislation.

• “The Next Asbestos Bankruptcy Wave? Asbestos Bankruptcies Impact on the Tort System,” Defense Research Institute (DRI) Asbestos Medicine Seminar, Nov. 4-5, 2021.

• Hearing testimony on H.B. 1428, Pennsylvania House Committee on Judiciary, PA, January 2016.